Wheaton et al., 2016 - Google Patents
The vitronectin RGD motif regulates TGF-β-induced alveolar epithelial cell apoptosisWheaton et al., 2016
View HTML- Document ID
- 16398671238791285289
- Author
- Wheaton A
- Velikoff M
- Agarwal M
- Loo T
- Horowitz J
- Sisson T
- Kim K
- Publication year
- Publication venue
- American Journal of Physiology-Lung Cellular and Molecular Physiology
External Links
Snippet
Transforming growth factor-β (TGF-β) is a critical driver of acute lung injury and fibrosis. Injury leads to activation of TGF-β, which regulates changes in the cellular and matrix makeup of the lung during the repair and fibrosis phase. TGF-β can also initiate alveolar …
- 210000002821 Alveolar epithelial cell 0 title abstract description 149
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wheaton et al. | The vitronectin RGD motif regulates TGF-β-induced alveolar epithelial cell apoptosis | |
Lagares et al. | ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis | |
Rubel et al. | Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice | |
Kim et al. | Epithelial cell α3β1 integrin links β-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis | |
Kubota et al. | M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis | |
Cipolla et al. | IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis | |
Mori et al. | Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts | |
Owen et al. | Regulation of lamellipodial persistence, adhesion turnover, and motility in macrophages by focal adhesion kinase | |
Yasar Yildiz et al. | Functional stability of plasminogen activator inhibitor‐1 | |
Besschetnova et al. | Regulatory mechanisms of anthrax toxin receptor 1-dependent vascular and connective tissue homeostasis | |
Rayego-Mateos et al. | Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis | |
Connolly et al. | Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation | |
Wypasek et al. | Mast cells in human stenotic aortic valves are associated with the severity of stenosis | |
Larsson et al. | Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells | |
Kalucka et al. | Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice | |
Trujillo et al. | Neutrophil recruitment to the lung in both C5a-and CXCL1-induced alveolitis is impaired in vitamin D–binding protein–deficient mice | |
Znoyko et al. | Expression of oncostatin M and its receptors in normal and cirrhotic human liver | |
Kanno et al. | Alpha2‐antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F2α synthesis through adipose triglyceride lipase/calcium‐independent phospholipase A2 | |
Wheaton et al. | Lung epithelial cell focal adhesion kinase signaling inhibits lung injury and fibrosis | |
Horowitz et al. | Urokinase plasminogen activator overexpression reverses established lung fibrosis | |
Kanno et al. | The antifibrotic effect of α2AP neutralization in systemic sclerosis dermal fibroblasts and mouse models of systemic sclerosis | |
Tang et al. | Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice | |
Leask | Suppl 1: Getting Out of a Sticky Situation: Targeting the Myofibroblast in Scleroderma | |
Ai et al. | Methyl-CpG-binding domain protein 2 contributes to renal fibrosis through promoting polarized M1 macrophages | |
Balsara et al. | A deficiency of uPAR alters endothelial angiogenic function and cell morphology |